|
Hearken to this text  |
A model of Endiatx’s PillBot as of June 2024. | Supply: Endiatx
Endiatx LLC is planning a pivotal trial for its swallowable, steerable Pillbot robotic digicam at Mayo Clinic campuses this yr.
The Hayward, Calif.–based mostly startup instructed MassDevice this week that it has already began its first in-human trials in New Zealand. Endiatx stated that it plans to publish information from these trials and that they’re “progressing effectively, and physicians admire the know-how.”
The corporate added that it intends to file for an investigational gadget exemption (IDE) from the U.S. Meals and Drug Administration this yr to start out the pivotal trial, to be performed at Mayo Clinic campuses. It additionally provided an replace on its fundraising, saying it has already secured $7 million from traders and is engaged on a $20 million Collection A spherical.
Endiatx co-founder and CEO Torrey Smith stated the newest model of PillBot has new optics with a 160° discipline of view (see video).
PillBot Model 1.0 has a 13 mm (0.5 in.) diameter and wi-fi distant management so a doctor can transfer the swallowable gadget round inside a affected person’s abdomen for visible inspection.
Endiatx envisions PillBot 2.0 as smaller, with 10 mm diameter and “AI-automated motion, lab-on-chip gut-biome evaluation, additional miniaturization, [and] AI diagnostics utilizing giant information pool.”
Later iterations may embody surgical instruments, Smith instructed Medical Design & Outsourcing (MDO, a sibling web site to The Robotic Report) in 2022.
Endiatx co-founder and CEO Torrey Smith with PillBot. | Supply: Hardy Wilson for MDO
Endiatx partnership with Mayo Clinic continues
Rochester, Minn.-based Mayo Clinic already has fairness in Endiatx by means of a 15-year know-how license settlement overlaying the system’s improvement.
Dr. Vivek Kumbhari, the chair of gastroenterology and hepatology at Mayo Clinic–Florida, joined the Endiatx board in 2021 and helped Endiatx with cadaver testing at Mayo Clinic.
Most just lately, Kumbhari offered a TED Discuss in April with Alex Luebke, co-founder, chair, and chief know-how officer of Endiatx, who swallowed a PillBot dwell on stage. That TED Discuss went dwell simply this week — watch it under:
Endiatx CEO to keynote RoboBusiness
Smith shall be keynoting RoboBusiness 2024, which takes place on the Santa Clara Conference Middle on Oct. 16 and 17. Throughout the keynote, Smith will give a dwell demo of Endiatx’s swallowable robotic tablet.
RoboBusiness is the premier occasion for industrial robotics builders. Attendees will acquire the newest insights from consultants in robotics and AI on cutting-edge analysis, trade traits, and modern functions. They will additionally find out about investments and subjects associated to operating a robotics enterprise.
With greater than 150 exhibitors on the present ground, there shall be loads of alternatives and particular occasions for robotics trade professionals to share insights, rejoice successes, overcome challenges, and extra. The improved present ground will embody new options resembling a Robotics Startup Zone, an Engineering Theater, and extra.
RoboBusiness shall be co-located with DeviceTalks West, the premier trade occasion for medical know-how professionals. DeviceTalks West attracts engineering and enterprise professionals from a broad vary of healthcare and medical know-how backgrounds, together with surgical robotics.
Editor’s word: This text was syndicated from The Robotic Report sibling web site MassDevice.
